| Name | The Pill Box Pharmacy |
|---|---|
| Organization Name | Pill Box Inc |
| Location | 1400 Sr 125, Amelia, Ohio 45102 |
| Type | Pharmacy |
| Phone | (513) 753-4700 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In the future, nurses may more accurately detect and alleviate symptoms of delirium in persons with dementia, thanks to a five-year, $2.7-million grant from the National Institute of Nursing Research.The project, led by Donna Fick, professor of nursing, Penn State, seeks to improve nurses' assessment skills and reduce the use of drugs to treat delirium and dementia.
Emmaus Medical, Inc., a pharmaceutical company developing a new treatment for sickle cell disease, and subsidiary of Emmaus Life Sciences, Inc., announced today that its investigational L-glutamine treatment for sickle cell disease has received a positive opinion recommending orphan medicinal product designation by the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP). The designation allows Emmaus ten years of marketing exclusivity in EU member countries after the product obtains marketing authorization, as well as streamlined regulatory review processes and registration and other fee reductions.
UCLA researchers led by Drs. Peiyee Lee and Richard Gatti at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have used induced pluripotent stem cells to advance disease-in-a-dish modeling of a rare genetic disorder, Ataxia Telangiectasia.
In an effort to combat eating disorders among adolescents, the Eating Disorder Research Program (EDRP) at University of the Sciences is offering free treatment for families with an adolescent who struggles with eating and weight concerns.
› Verified 7 days ago
| NPI Number | 1629067343 |
| Organization Name | THE PILL BOX INC |
| Type | Pharmacy |
| Address | 245 W Main St, Amelia, OH 45102 |
| Phone Number | 513-753-4700 |
News Archive
In the future, nurses may more accurately detect and alleviate symptoms of delirium in persons with dementia, thanks to a five-year, $2.7-million grant from the National Institute of Nursing Research.The project, led by Donna Fick, professor of nursing, Penn State, seeks to improve nurses' assessment skills and reduce the use of drugs to treat delirium and dementia.
Emmaus Medical, Inc., a pharmaceutical company developing a new treatment for sickle cell disease, and subsidiary of Emmaus Life Sciences, Inc., announced today that its investigational L-glutamine treatment for sickle cell disease has received a positive opinion recommending orphan medicinal product designation by the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP). The designation allows Emmaus ten years of marketing exclusivity in EU member countries after the product obtains marketing authorization, as well as streamlined regulatory review processes and registration and other fee reductions.
UCLA researchers led by Drs. Peiyee Lee and Richard Gatti at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have used induced pluripotent stem cells to advance disease-in-a-dish modeling of a rare genetic disorder, Ataxia Telangiectasia.
In an effort to combat eating disorders among adolescents, the Eating Disorder Research Program (EDRP) at University of the Sciences is offering free treatment for families with an adolescent who struggles with eating and weight concerns.
› Verified 7 days ago
News Archive
In the future, nurses may more accurately detect and alleviate symptoms of delirium in persons with dementia, thanks to a five-year, $2.7-million grant from the National Institute of Nursing Research.The project, led by Donna Fick, professor of nursing, Penn State, seeks to improve nurses' assessment skills and reduce the use of drugs to treat delirium and dementia.
Emmaus Medical, Inc., a pharmaceutical company developing a new treatment for sickle cell disease, and subsidiary of Emmaus Life Sciences, Inc., announced today that its investigational L-glutamine treatment for sickle cell disease has received a positive opinion recommending orphan medicinal product designation by the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP). The designation allows Emmaus ten years of marketing exclusivity in EU member countries after the product obtains marketing authorization, as well as streamlined regulatory review processes and registration and other fee reductions.
UCLA researchers led by Drs. Peiyee Lee and Richard Gatti at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have used induced pluripotent stem cells to advance disease-in-a-dish modeling of a rare genetic disorder, Ataxia Telangiectasia.
In an effort to combat eating disorders among adolescents, the Eating Disorder Research Program (EDRP) at University of the Sciences is offering free treatment for families with an adolescent who struggles with eating and weight concerns.
› Verified 7 days ago
Cvs Pharmacy #07776 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 52w Main St, Amelia, Ohio 45102 Phone: (513) 943-6201 | |
Walgreens #7489 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 57 W Main St, Amelia, Ohio 45102 Phone: (513) 752-7131 | |
Kroger Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2620 W Main St, Amelia, Ohio 45102 Phone: (513) 718-2220 | |
Wal Mart Pharmacy 10-3342 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1815 State Route 125, Amelia, Ohio 45102 Phone: (513) 797-1250 |